IRIS
RENDA, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.264
EU - Europa 2.944
AS - Asia 1.245
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 7.468
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.255
IE - Irlanda 686
CN - Cina 658
UA - Ucraina 627
TR - Turchia 472
SE - Svezia 468
IT - Italia 399
GB - Regno Unito 250
DE - Germania 178
FR - Francia 149
FI - Finlandia 119
IN - India 56
BE - Belgio 21
IR - Iran 20
PL - Polonia 18
VN - Vietnam 16
EU - Europa 10
HK - Hong Kong 9
CA - Canada 8
RU - Federazione Russa 7
IL - Israele 4
NL - Olanda 4
RO - Romania 4
DK - Danimarca 3
JP - Giappone 3
AT - Austria 2
BR - Brasile 2
HU - Ungheria 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
CY - Cipro 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
RS - Serbia 1
Totale 7.468
Salva come PNG Salva come JPEG
Città #
Jacksonville 762
Dublin 669
Chandler 649
Princeton 339
Izmir 225
Nanjing 201
Southend 196
Ashburn 147
Altamura 118
Cambridge 117
Dearborn 117
Wilmington 113
Beijing 104
Nanchang 88
Ann Arbor 79
Chieti 60
Hebei 39
Shenyang 38
Woodbridge 38
Kunming 37
Boardman 35
Los Angeles 29
New York 29
Tianjin 25
Washington 24
Augusta 23
Jiaxing 23
San Mateo 23
Grevenbroich 22
Norwalk 22
Brussels 21
Changsha 21
Leawood 20
Ardabil 17
Dong Ket 15
Falls Church 15
Kraków 15
Pescara 15
Hangzhou 14
Houston 11
Hefei 10
Helsinki 9
Hong Kong 8
Lanzhou 8
Guangzhou 7
Seattle 7
Taizhou 7
Toronto 7
Jinan 6
Monmouth Junction 6
Bologna 5
Düsseldorf 5
Amsterdam 4
Auburn Hills 4
Beersheba 4
Brindisi 4
Fort Worth 4
Fuzhou 4
L'aquila 4
Milan 4
Mumbai 4
Ningbo 4
Redwood City 4
Rome 4
Tappahannock 4
Teramo 4
Bangalore 3
Campodipietra 3
Changchun 3
Florence 3
Intra 3
Kocaeli 3
Mountain View 3
Penne 3
Pune 3
Solofra 3
Spoltore 3
Zhengzhou 3
Ardea 2
Bari 2
Budapest 2
Caiatia 2
Chicago 2
Chongqing 2
Copenhagen 2
Cormeilles-en-Parisis 2
Giulianova 2
London 2
Orange 2
Osimo 2
Redmond 2
Roseto Degli Abruzzi 2
Salerno 2
Serra 2
Tokyo 2
Torino 2
Treglio 2
Trevi 2
Valea 2
Anaheim 1
Totale 4.775
Salva come PNG Salva come JPEG
Nome #
Increased left atrial size in obese children and its association with insulin resistance: a pilot study 117
Response to "Pharmacodynamic Interaction Between Aspirin and Ibuprofen: A Plausible Mechanism of Aspirin Resistance" 104
Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents 94
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial 93
Intracardiac thrombi during warfarin anticoagulation - A case report and a brief literature review 86
Genetic determinants of blood pressure responses to caffeine drinking 82
Aneurisma coronarico: scoperta generalmente casuale, prognosi sempre severa? 81
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy 81
Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery 80
Effects of endurance, resistance and neuro-muscular electrical stimulation trainings to the anthropometric and functional mobility domains in elderly 80
Genetic determinants of cognitive responses to caffeine drinking identified from a double-blind, randomized, controlled trial 79
Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects 78
La gestione del rischio tromboembolico nei pazienti con fibrillazione atriale in Italia: Dati al follow-up del Registro Europeo PREFER in AF 78
Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences 77
Failure in evoking the trigeminal cardiac reflex by mandibular stretching in healthy volunteers 77
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 75
Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease 75
Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin 74
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies 73
INCREASED THROMBOXANE PRODUCTION BY MONOCYTE PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-2 IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. 71
Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions 70
Facilitated PCI: Rationale, current evidence, open questions and future directions 70
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease 69
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 69
The left atrial appendage: from embryology to prevention of thromboembolism 69
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 68
Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries 68
The Role of Multimodality Cardiovascular Imaging in Peripartum Cardiomyopathy 67
Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation ∗ 66
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial 66
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects 65
Edoxaban for the Prevention of Thromboembolism in Patients with Atrial Fibrillation and Bioprosthetic Valves 65
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper 64
Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF 64
EFFECTS OF NIMESULIDE ON CONSTITUTIVE AND INDUCIBLE PROSTANOID BIOSYNTHESIS IN MAN. 63
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W 63
Incomplete suppression of platelet COX-1 activity associated with aspirin-resistant thromboxane biosynthesis in acute coronary syndromes 63
An early decline of collateral circulation parallels myocardial ischaemia during percutaneous coronary intervention: a drawback of recanalization of chronic coronary occlusions? 63
Non-vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation - An Updated Meta-analysis 62
Coffee: Health Effects 62
AF: current and forthcoming antithrombotic therapies 62
New anticoagulants for atrial fibrillation 61
Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry 61
Antithrombotic therapy in atrial fibrillation: state of the art and perspectives. 60
Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy 60
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 59
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease 59
Prognostic significance of noncardiac syncope in the general population: A systematic review and meta-analysis 59
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation 59
Dose- Dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects. 58
Cardiovascular and psychological reactivity after caffeine consumption 58
Cardiovascular effects of caffeine during cognitive tasks 57
Atrial and left atrial appendage thrombosis in patients with atrial fibrillation: from pathophysiology to treatment 57
Systolic and diastolic dysfunction occurs in newly diagnosed patients with hypertension and high systolic blood pressure variability 56
MECHANISMS OF ISOPROSTANE BIOSYNTHESIS IN HUMANS 55
Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects 55
Blood pressure modifications after caffeine intake during cognitive tasks 55
Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study 55
CHA2DS2VASc score and adverse outcomes in middle-aged individuals without atrial fibrillation 55
A comparison between unfractioned heparin and a low molecular weight heparin in cardiac surgery 54
Antithrombotic management 54
Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban 53
The AVERROES Trial – Clinical Implications 53
Enhanced thromboxane biosynthesis in patients with colorectal and lung cancer 53
DIFFERENTIAL INHIBITION OF HUMAN PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-1 AND -2 BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 52
Parmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects 52
Systolic and diastolic dysfunction occurs in newly diagnosed patients with hypertension and high systolic blood pressure variability 52
Antithrombotic prophylaxis in the elderly with atrial fibrillation 52
EFFECTS OF NIMESULIDE ON CONSTITUTIVE AND INDUCIBLE PROSTANOID BIOSYNTHESIS IN HUMAN BEINGS 51
Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe. 51
The legacy of ISCHEMIA 51
ENHANCED CORTISOL SECRETION DOES NOT CONTROL ASPIRIN-INSENSITIVE THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES. 50
Autonomic nervous system dysfunction in obese children 50
Surgical bleeding after preoperative unfractionated heparin and low molecular weight heparin at coronary bypass surgery 50
ENHANCED CORTISOL SECRETION DOES NOT CONTROL ASPIRIN-INSENSITIVE THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES 49
Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension 49
Nutrigenetics of blood pressure responses to coffee drinking 49
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 49
Effect of fibrinogen concentration on the antiplatelet effect of tirofiban 49
A comparison between unfractionated heparin and a low molecular weight heparin in cardiac surgery 48
Systolic blood pressure response to coffee is modulated by alpha2B adrenergic receptor I/D polymorphism 48
Ruolo del fibrinogeno e della conta piastrinica sull’inibizione dell’aggregazione piastrinica da parte dei farmaci anti-glicoproteina IIbIIIa 48
P6223Relationship between platelet indices and future cardiovascular events: results from a population-based cohort study 48
Late coronary thrombosis after drug-eluting stent: stent vs patient-driven prescription of aspirin-clopidogrel combination 48
Prognostic value of non-resistant and resistant masked uncontrolled hypertension detected by ambulatory blood pressure monitoring 48
Aspirin Resistance 47
Triple antithrombotic therapy with aspirin, clopidogrel and warfarin – a persisting dilemma 47
Circadianicity of hemostatic function and coronary vasomotion 46
Celecoxib, ibuprofen and the antiplatelet effect of aspirin in patients with osteoarthritis and chronic stable angina 46
Systolic blood pressure variability by non-invasive monitoring predicts intima-media thickness independent of absolute blood pressure levels 46
Aspirina ed ACE-inibitori. Una partita ancora aperta? 46
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 46
Systolic blood pressure variability by non-invasive monitoring predicts intima-media thickness independent of absolute blood pressure levels 45
Terapia dell’infarto miocardico e delle sindromi coronariche 45
Impact of antiplatelet therapy in heart disease 45
Anticoagulant Therapy in Atrial Fibrillation – Time for a Change? 45
Inhibitory effect of coffee on platelet aggregation 45
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation 45
Inconsistency of different methods for assessing ex vivo platelet function: relevance for the detection of aspirin resistance 44
Images in cardiovascular medicine. Membrane-type subaortic stenosis in the adult. 44
Totale 6.065
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.803
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.803
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019279 0 0 0 0 0 0 0 0 0 0 10 269
2019/20201.595 521 122 13 47 141 79 194 150 62 98 162 6
2020/2021951 131 4 145 25 112 171 22 22 36 103 142 38
2021/2022693 12 5 5 126 82 8 17 62 64 18 72 222
2022/20232.007 183 282 117 193 181 392 140 137 268 23 51 40
2023/2024824 75 17 57 11 51 300 221 46 11 29 6 0
Totale 8.054